FDA’s McClellan To Testify On Rx Imports Before Senate Commerce Cmte. March 11
This article was originally published in The Pink Sheet Daily
Executive Summary
The hearing appears to have been scheduled to facilitate speedy approval of the FDA commissioner’s nomination to head the Centers for Medicare & Medicaid Services.
You may also be interested in...
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.